alprax 2 alprazolam 2mg tablet bottle
aspen pharma pty ltd - alprazolam, quantity: 2 mg - tablet, uncoated - excipient ingredients: sodium benzoate; docusate sodium; maize starch; magnesium stearate; colloidal anhydrous silica; sodium starch glycollate; povidone; microcrystalline cellulose; lactose - anxiety: the short-term symptomatic treatment of anxiety including treatment of anxious patients with some symptoms of depression, and panic disorder: the treatment of panic disorder with or without some phobic avoidance, and for blocking or attenuation of panic attacks and phobias in patients who have agoraphobia with panic attacks.
alprax 1 alprazolam 1mg tablet blister pack
aspen pharma pty ltd - alprazolam, quantity: 1 mg - tablet, uncoated - excipient ingredients: indigo carmine; docusate sodium; sodium benzoate; lactose; sodium starch glycollate; povidone; magnesium stearate; maize starch; colloidal anhydrous silica; microcrystalline cellulose - anxiety: the short-term symptomatic treatment of anxiety including treatment of anxious patients with some symptoms of depression, and panic disorder: the treatment of panic disorder with or without some phobic avoidance, and for blocking or attenuation of panic attacks and phobias in patients who have agoraphobia with panic attacks.
alprax 0.5 alprazolam 0.5mg tablet blister pack
aspen pharma pty ltd - alprazolam, quantity: 0.5 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; maize starch; lactose; povidone; sodium benzoate; magnesium stearate; microcrystalline cellulose; docusate sodium; sodium starch glycollate; colour - anxiety: the short-term symptomatic treatment of anxiety including treatment of anxious patients with some symptoms of depression, and panic disorder: the treatment of panic disorder with or without some phobic avoidance, and for blocking or attenuation of panic attacks and phobias in patients who have agoraphobia with panic attacks.
alprax xr 1 xr tablet
opsonin pharma limited - alprazolam - xr tablet - 1 mg
alprax xr 2 xr tablet
opsonin pharma limited - alprazolam - xr tablet - 2 mg
alprax
aspen pharma pty ltd - alprazolam -
alpax ampoules 2 ml 2 mg/ml
شركة أدوية الحكمة - hikma pharmaceuticals - pancuronium bromide 2 mg/ml - 2 mg/ml
alprax 1 alprazolam 1mg tablet bottle
aspen pharma pty ltd - alprazolam, quantity: 1 mg - tablet, uncoated - excipient ingredients: maize starch; povidone; sodium benzoate; sodium starch glycollate; indigo carmine; microcrystalline cellulose; docusate sodium; magnesium stearate; colloidal anhydrous silica; lactose - anxiety: the short-term symptomatic treatment of anxiety including treatment of anxious patients with some symptoms of depression, and panic disorder: the treatment of panic disorder with or without some phobic avoidance, and for blocking or attenuation of panic attacks and phobias in patients who have agoraphobia with panic attacks.
alprax 0.5 alprazolam 0.5mg tablet bottle
aspen pharma pty ltd - alprazolam, quantity: 0.5 mg - tablet, uncoated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; lactose; sodium starch glycollate; microcrystalline cellulose; povidone; sodium benzoate; maize starch; docusate sodium; colour - anxiety: the short-term symptomatic treatment of anxiety including treatment of anxious patients with some symptoms of depression, and panic disorder: the treatment of panic disorder with or without some phobic avoidance, and for blocking or attenuation of panic attacks and phobias in patients who have agoraphobia with panic attacks.
alprax 0.25 alprazolam 0.25mg tablet blister pack
aspen pharma pty ltd - alprazolam, quantity: 0.25 mg - tablet, uncoated - excipient ingredients: sodium starch glycollate; lactose; docusate sodium; maize starch; microcrystalline cellulose; magnesium stearate; povidone; colloidal anhydrous silica; sodium benzoate - anxiety: the short-term symptomatic treatment of anxiety including treatment of anxious patients with some symptoms of depression, and panic disorder: the treatment of panic disorder with or without some phobic avoidance, and for blocking or attenuation of panic attacks and phobias in patients who have agoraphobia with panic attacks.